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Abstract 
        Background: Several studies have been focused on interstitial lung disease among patients with 
established rheumatoid arthritis, with  fluctuating incidence and prevalence depending on the methods 
used. 
       Patients and Methods: A case- control study design was used in this study performed on 100 
cases with RA (50 cases with ILD). Data were analyzed by using Statistical Package of Social Sciences 
(SPSS)  version18. Categorical variables were presented as frequencies and percentages. Continuous 
variables were presented as means with their  confidence interval (CI) and standard deviation. The 
Pearson's chi-square test was used to determine the associations between  categorical variables. A p-
value of < 0.05 was considered as statistically  significant 
Keywords: Rhenmatoid arthritis, interstitial lung disease, HRCT. 
Introduction 
Background  1.1 
Interstitial  Lung  Disease  (ILD) is a progressive fibrotic disease of the lung 
parenchyma occurs  in  association  with  several rheumatic  diseases  including  
rheumatoid  arthritis  (RA). An association  a between  positive  rheumatoid  factor  
and  ILD  in  RA  is  well established. ILD is  the  only  complication  of  RA  
reported  to  be  increasing  in  prevalence worldwide, as well as, it has been shown to 
be approximate of 6% for all RA deaths[1&2]  Several studies  revealed  a high post-
mortem occurrence  of RA ILD,  which  has  been  subsequently  supported  by  high-
resolution  computed tomography (HRCT) to be out of 25% for all RA patients[3&4] 
  (Rheumatoid Arthritis (RA 1.2 
Rheumatoid  arthritis  (RA)  is  one  of  the  most  important  chronic  
inflammatory disorders that affect the joints and musculoskeletal systems. It is  
associated  with  swelling,  stiffness,  pain  and  may  lead  to  substantial  loss  of 
functioning and mobility in severe cases[1]. 
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Pulmonary Involvement in Rheumatoid Arthritis Patients  1.3 
      RA is an autoimmune disease in which the body attacks its own tissue and it may 
affect the  lungs.  Since,  1948, Ellman and Ball  described  three  cases  with  classic  
manifestations  of  RA  and  extensive pulmonary  involvement[5]  
     However,  the  nature  of  the  relationship  between inflammation  in  lungs  and  
joints  is  still  unclear.  Several  studies  have  been  focused  on  ILD  among  
patients  with  established  RA,  with  fluctuating  incidence and prevalence depending 
on the methods  used [1,4, 6,7, 8,9,10,11] . 
     The  incidence  of  RA associated lung disease has been increasing, as a result of 
improved availability of  diagnostic  tests [10]. there  is limited data on obstructive 
pulmonary disease in RA,  however, a study done  by  Geddes  et  al  found  that  32%  
of  patients  with  established  RA  had  an obstructive lung disease, based on standard 
pulmonary function tests[4]  Intrapulmonary  rheumatoid  nodules  is  typical  
pleuropulmonary manifestations for RA,  meanwhile, pulmonary complications are 
common and  responsible  for  10  to  20%  of  all  mortality[12&13]  have respiratory 
symptoms patients However,  approximately  one-third  of  the  RA    and  two-thirds  
had  significant [1] on high-resolution computed tomography[14] radiographic 
abnormalities ILD  presentations  vary  from  asymptomatic  to  severe,  rapidly 
progressive  shortness  of  breath  as  well  as  respiratory  failure  and  death. 
According  to  presentation  ILD  can  be  classified  into  acute  presenting symptoms,  
chronic  slowly  progressive  symptoms.  Meanwhile,  ILD  can  be  presented with an 
abnormal chest radiograph or abnormal pulmonary function test but with no 
symptoms[15] progressive dysponea with or However, ILD  most common 
presentation is slow without cough.  
Diagnosis of Interstitial Lung Disease 1.5 
Symptoms  of  ILD  are  major  stone  in  diagnosis.  Patients  usually  presented  
with  increasing  exertional  breathlessness,  dry  cough  as  well  as increasing  
fatigue  which becomes an invariable feature  once hypoxia develops [15].  Meanwhile, 
Physical  signs  of ILD  include bi-basal lung crackles, initially  fine  and  heard  in  
late  inspiration,  progressing  to  louder  coarser  crepitation audible  throughout  
inspiration.  Finally, finger clubbing which is relatively uncommon occurring in less 
than 20% of patients.  However, central cyanosis may accompany resting hypoxia 
which can lead to  low oxygen saturations  at  rest. Hypercapnia is the end-stage of 
advanced ILD.   
       Normal chest radiography did not exclude  RA-ILD. However  established 
disease will usually be  visible as reticular shadowing accompanied by increasingly 
nodular opacification of the lower lobes[16]. or coin lesion ,or lobar collapse is 
pathognomonic  An isolated nodule  High resolution  CT of the thorax provides much 
more definitive information  and is  required  to  make  a confident  diagnosis  of  
ILD.   Furthermore,  it  establishes  the  type  of  ILD  assesses  disease  and finally  
excludes  of  other  pathologies  that  might  mimic ILD[17] Serological  test  
represented  by  Cyclic  Citrullinated  Peptides  (CCP)  antibodies  is  likely  to  be  
positive  in  ILD  and  may  precede  the  onset  of  RA especially in smokers[18&19]. 
the development of RA include  There  are ranges of lung abnormalities during 
airways disease and might suggest the lung as a site of initiation of RA [20&21]. 
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1.6 Aim of the study 
This  study  has  been  carried  out  to  determine  the  risk  of  developing  of  
interstitial  lung  disease  in RA patients. 
1.7 Patients and method 
2.1 Study Design 
This was a hospital based case-control study which conducted to determine the 
association of RA patients by socio-demographic characteristics and other study 
variables performed on 100 cases with RA (50 cases of them diagnosed to have ILD 
by chest physicion based on clinical data radiological, PFT, histological), at Baghdad 
Medical City from September2013  to September 2014                                                                                                           
Data Collection 2.2 
The Inclusion and exclusion criteria for the cross-sectional study groups were as 
follows: 
a) Inclusion criterion:  RA patient with &without ILD with age group 20-above 60 
years. 
b) Exclusion criterion : 
 1. IHD& Heart failure. 
2.  Chronic lung disease as asthma, COPD. 
3. Drugs as biological agent, MTX. 
4. Other CTD as SLE, Mixed CTD. 
  2.3 Study Instruments 
Structured questionnaire consists of duration of RA, serology test, presence of 
subcutaneous nodules and pulmonary nodules.. 
2.4 Data Analysis 
Statistical analysis was carried out using SPSS version 18. Categorical variables 
were presented as frequencies and percentages. Pearson’s chi square (x2) test and 
fisher exact test were used to find the association between the categorical variables. A 
p-value of ≤ 0.05 was considered as significant. 
The Association of RA Patients with Duration of RA, DAS 28  
Serology Test, Presence of Subcutaneous Nodule and Pulmonary  
Nodules 
Table-1: shows the association of RA patients with and without ILD with duration of 
RA, DAS 28, serology test, presence of subcutaneous nodules and pulmonary 
nodules. There was significant association between RA patients and serology test, RA 
patients with ILD were seven times more likely to have a positive test. There was 
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significant association between RA patients and presence of pulmonary nodules; RA 
patients without ILD were nine times more likely to do not have pulmonary nodules 
by chest x-ray. 
P value OR 
95% C.I 
X2 RA patients 
without ILD 
% 
RA patients  
With ILD % 
Variables 
 
 
0.126 
 
 
0.88(0.31-2.45) 
0.47(0.14-1.54) 
0.28(0.08-0.94) 
 
 
5.72 
 
17 (34.0) 
19(38.0) 
8 (16) 
6 (12) 
 
11 (22.0) 
14 (28.0) 
11 (22.0) 
14 (28.0) 
Duration of RA 
<6 years  
6-12 years 
13-18years 
>18years 
 
 
0.139 
 
 
0.61(0.26-1.45) 
0.30(0.09-1.04) 
 
 
3.94 
 
24 (48.0) 
21 (42) 
5 (10.0) 
 
16 (32.0) 
23 (46.0) 
11 (22) 
DAS 28 
Mild disease activity 
Moderate disease activity  
Sever disease activity 
 
 
0.005* 
 
3.22 (1.41-7.35) 
 
7.95 
 
21 (42.0) 
29 (58.0) 
 
35 (70.0) 
15 (30.0) 
Serology Test  
Positive 
negative 
 
 
0.205 
 
 
1.71 (0.74-3.96) 
 
 
1.60 
 
 
14 (28.0) 
36 (72.0) 
 
 
20 (40.0) 
30 (60.0) 
Presence of 
subcutaneous nodule 
Yes  
no 
 
 
 
0.002* 
 
 
2.22 (1.77-2.78) 
 
 
9.89 
 
 
0 (0.0) 
50 (100.0) 
 
 
9 (18.0) 
41 (82.0) 
Presence of pulmonary 
nodule 
Yes  
no 
*p value ≤ 0.05 is significant 
Discussion  
Rheumatoid arthritis is traditionally considered a disease that involves  the joints. 
Nevertheless, up to 50% of the patients have some type of extra articular 
manifestations, such as serositis, pneumonitis, peripheral neuritis ,nodules, and 
sclerosis. Pulmonary involvement is a frequent and among the most severe extra-
articular manifestations of RA ranking as the second cause of mortality in this patient 
population [22] 
       This current study reported no significant association between presence  of ILD 
and duration of RA, however, it has not agreed with Vergnenègre and  his co-workers 
in France 1997, meanwhile, it is agreed with Bongartz et al in 2010 in America 
revealed that there was not significant association between presence of ILD and 
duration of RA  [1&22]. 
     There was no significant  association between DAS 28 and presence of ILD in 
current study which agreed with Harlow and its co-workers research in USA 2013, 
who reported  that, there were no significant differences between parameters diseases 
activity  like ESR and DAS 28 by RA patients with or without ILD[24] 
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      The present study findings found that, there was significant association between 
presence of ILD in RA patients and positive serological test. RA  patients were ten 
times more likely to suffer from ILD. This finding was in agreement with study in 
America in 2012 by Fischer and his co-workers who  found that, serological test for 
Rheumatoid factor were in higher rate for RA patients with ILD[1] 
     Meanwhile, the present study reported that RA patients with ILD were eight times 
more likely to have subcutaneous nodules which  were the similar to Bongartz et al in 
2010 in America who found that RA patients without ILD were two times more likely 
to have subcutaneous nodules[1] 
       In addition, Saag et al. 1997 in USA found that smoking cigarette more  than 25 
pack-years were significantly associated with higher titer or  Rheumatoid factor as 
well as presence of subcutaneous nodules in RA patient with ILD [25] . 
Conclusion  
RA patients were (ten times) more likely to suffer from ILD Meanwhile, this 
study reported that RA patients without ILD were (nine times) more likely to do not 
have pulmonary nodules. 
 
Recommendation 
Further studies will be required to establish the exact relationship between the 
ILD and RA, and to throw further light on the pathophysiological mechanism 
involved. 
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 ةالخلاص
 حدوث ومع الراسخة، الرثياني المفاصل بالتهاب المصابين المرضى بين الخلالي الرئة أمراض في عديدة دراسات ركزت لقد :الخلفية
 .المستخدمة الأساليب على اعتمادا ً تقلبات
 الرثياني لمرضى الديمغرافية الاجتماعية الخصائص حسب الخلالي الرئة بأمراض الإصابة خطر لتحديد الدراسة هذه أجريت قد :الهدف
 .الأخرًى الدراسة ومتغيرات
 للعلوم الإحصائية الحزمة باستخدام البيانات تحليل تم ،وقد الدراسة هذه في التحكم الحالة دراسة تصميم تم :والطرق  المرضى
 كوسيلة المستمرة المتغيرات وعرضت المئوية، النسب و الترددات قاطعة المتغيرات وعرضتً، 81 الإصدار ) SSPS ( الاجتماعية
 بين الروابطًلتحديد استخدامه تم )2x ( مربع اختبار تشي بيرسوًن .المعيارًي والانحراف  )IC(  الثقة فاصل %59 أصدقائهم مع
 .إحصائيا كماً  𝑝 > 50.0قيمة واعتبرت .الفئوية المتغيرات
 الذين الرثياني المفاصل التهاب مرضى في الخلالي الرئة أمراض من مرة 51 معدل أعلى ان ذكرت الحالية الدراسة نتيجة : الاستنتاج
 للاصابه مرتين أعلى كانت الدراسة هذه في الحاليين المدخنين كذلك، او ًالمصانع، الكهربائية المولدات من المنطقة قرب يعيشوًن
 عدم مرات بثلاث أعلى كانت المدخنين غير عن فضلا المفاصل، التهاب مرضى بين الخلاليه الرئة بأمراض
 .الخلالي الرئة أمراض تقديم
 التهابًالمفاصلًالرثوي،ًامراضًالرئةًالخلاليةً،ًمفراسًالصور.ًًالكلمات الدالة:
 
